Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
>=3.0-<5.0%
EC/CAS
1305-78-8
Name of the chemical
Calcium oxide
Concentration
>=1.0-<3.0%
EC/CAS
8052-41-3
Name of the chemical
Stoddard Solvent; Naphtha (petroleum), hydrodesulfurized heavy
Concentration
>=1.0-<3.0%
EC/CAS
91-08-7
Name of the chemical
2,6-Diisocyanattoluol
Concentration
>=0.3-<1.0%
EC/CAS
2530-83-8
Name of the chemical
[3-(2,3-epoxypropoxy)propyl]trimethoxy silane
Concentration
>=0.2-<0.3%
EC/CAS
1333-86-4
Name of the chemical
carbon black
Concentration
>=0.1-<0.2%
EC/CAS
149-57-5
Name of the chemical
2-ethylhexanoic acid
Concentration
>0.0-<0.1%
General Information
Version
2.0
Revision date
2015-07-15
Product name
MasterSeal SL 1 gray
Chemical name
sealant
1.2.1 Relevant identified uses
for industrial and professional users * The “Recommended use” identified for this product is provided solely to comply with a Federal requirement and is not part of the seller"s published specification. The terms of this Safety Data Sheet (SDS) do not create or infer any warranty, express or implied, including by incorporation into or reference in the seller"s sales agreement
Emergency telephone
+1 973 245-6000, 1-800-424-9300
Icons in SDS
Company Information
company name
BASF CORPORATION
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H227, H317, H319, H334, H351, H361, H372
Hazard statements
Code
Statements
H227
Combustible liquid
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Flam. Liq. 4 Flammable liquids Eye Dam./Irrit. 2A Serious eye damage/eye irritation Resp. Sens. 1 Respiratory sensitization Skin Sens. 1 Skin sensitization Carc. 2 Carcinogenicity Repr. 2 (unborn child) Reproductive toxicity STOT RE 1 Specific target organ toxicity — repeated exposure
Signal word
Danger
Hazard statements
H227 Combustible liquid. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. H361 Suspected of damaging the unborn child. H372 Causes damage to organs (Central nervous system) through prolonged or repeated exposure.
Prevention
P280 Wear protective gloves/protective clothing/eye protection/face protection. P260 Do not breathe dust/gas/mist/vapours. P201 Obtain special instructions before use. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P202 Do not handle until all safety precautions have been read and understood. P284 In case of inadequate ventilation wear respiratory protection. P270 Do not eat, drink or smoke when using this product. P264 Wash with plenty of water and soap thoroughly after handling. P272 Contaminated work clothing should not be allowed out of the workplace.
Response
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P314 Get medical advice/attention if you feel unwell. P308 + P311 IF exposed or concerned: Call a POISON CENTER or doctor/physician. P303 + P352 IF ON SKIN (or hair): Wash with plenty of soap and water. P362 + P364 Take off contaminated clothing and wash before reuse. P337 + P311 If eye irritation persists: Call a POISON CENTER or doctor/physician. P370 + P378 In case of fire: Use water spray, dry powder, foam or carbon dioxide for extinction.
Storage
P405 Store locked up. P403 + P235 Store in a well-ventilated place. Keep cool.
Precautionary statements
(Disposal) P501 Dispose of contents/container to hazardous or special waste collection point.
2.3 Other hazards
If applicable information is provided in this section on other hazards which do not result in classification but which may contribute to the overall hazards of the substance or mixture. Labeling of special preparations (GHS) SENSITIZATION CAN OCCUR IN SOME INDIVIDUALS, LEADING TO ASTHMA-LIKE SPASMS OF THE BRONCHIAL TUBES AND DIFFICULTY BREATHING. INDIVIDUALS WITH A HISTORY OF RESPIRATORY ILLNESS, ASTHMATIC CONDITIONS, EYE DAMAGE OR TDI SENSITIZATION SHOULD NOT BE EXPOSED TO THIS PRODUCT. TDI IS INCLUDED IN THE NTP ANNUAL REPORT ON CARCINOGENS. RESULTS FROM A TDI HEALTH STUDY INDICATE THAT OVEREXPOSURE TO A RESPIRATORY IRRITANT, RESULTING IN LOWER RESPIRATORY TRACT SYMPTOMS COULD INCREASE THE RISKS OF DEVELOPING ASTHMA-LIKE REACTIONS FROM SUBSEQUENT TDI EXPOSURE.